Recently,The official delivery of the YJZ-12000 drug transdermal diffusion device by YiyanPONY Group, a well-known third-party testing and certification organization in China. The introduction of this high-precision experimental equipment will further improve the technical capabilities of Puni Group in the fields of drug transdermal release detection, cosmetics transdermal absorption research, etc., providing more professional and efficient in vitro release testing (IVRT) solutions for pharmaceutical companies, research institutions, and cosmetics industry customers, and helping the industry innovate research and development and improve quality standards.

As a popular direction in the fields of medicine and cosmetics in recent years, the precise detection of in vitro release rate and penetration degree of transdermal absorption preparations is a key link in screening effective ingredients, optimizing formula design, and ensuring product safety and effectiveness. Yiyan YJZ-12000 Transdermal Diffuser as an Industry Technology*firstThe precision experimental device adopts the internationally recognized diffusion pool principle, which can objectively and accurately simulate the permeation process of drug formulations through animal live skin (or inert artificial membranes) in specified solvents, providing scientific and reliable data support for scientific research and detection work.

From the perspective of technical performance, the YJZ-12000 drug transdermal diffusion instrument from Yiyan has multiple core advantages, and Wanmei meets the high requirements of the Funi Group for detection accuracy and experimental efficiency. The device is equipped with 12 transdermal cups, which can conduct multiple experiments simultaneously, greatly improving the detection throughput; The stable control of the pool volume is 15ml, combined with precise transdermal area design to ensure consistency and repeatability of experimental conditions; The temperature control range covers room temperature to 40 ℃, with a temperature control accuracy of up to ± 0.3 ℃. Through high-precision temperature sensors and a circulating water bath constant temperature system, the experimental environment is stabilized at a constant temperature to meet the testing needs of different dosage forms (semi-solid, paste, etc.). In addition, the device supports a mixing speed range of 100-1000r. p.m, with a speed accuracy controlled within ± 5%. With a flexible timing range of 0-99 hours and 59 minutes, it can accurately match the parameter requirements of various experimental schemes.

In terms of operational convenience and data management, the YJZ-12000 transdermal diffusion instrument from Yiyan also performs outstandingly. The equipment adopts microcomputer measurement and control technology, combined with a full LCD screen display and touch based operation interface, allowing experimenters to quickly complete parameter settings, start operation, and data viewing; Support 1-12 sampling settings, built-in data storage function, and the ability to export experimental data through a USB flash drive, facilitating subsequent data organization, analysis, and report generation, effectively reducing manual operation errors, and improving the traceability of experimental data. At the same time, the device has real-time temperature calibration function and over temperature protection mechanism - when the water bath temperature exceeds 40 ℃, the screen will immediately display an over temperature warning and trigger a buzzer alarm, ensuring the safety and stability of the experimental process.

As a leading enterprise in the domestic third-party testing industry, Puni Group has always been committed to providing customers with "one-stop" testing and certification services. Its testing capabilities cover multiple fields such as medicine, cosmetics, food, and the environment. The purchase of YJZ-12000 transdermal diffusion analyzer is not only an important supplement to its own pharmaceutical and cosmetics testing product line, but also a practice of the concept of "technology innovation driven service upgrade". According to the head of Puni Group's laboratory, the equipment will be mainly used for in vitro release testing of drug transdermal preparations, evaluation of transdermal absorption efficiency of active ingredients in cosmetics, and other scenarios. It can support animal skin such as pig skin, mouse skin, rabbit skin, as well as artificial membranes such as polyether sulfone, cellulose acetate, nylon mixed fat, etc. The testing requirements meet the diverse experimental needs of different customers.

In the field of pharmaceutical research and development, in vitro release testing of transdermal formulations is a key link in drug screening and formulation optimization; while in the cosmetics industry, the transdermal absorption effect of active ingredients is directly related to product efficacy and consumer experience. "The introduction of the YJZ-12000 drug transdermal diffusion analyzer by Yiyan will help us provide customers with more accurate and efficient detection services, such as drawing the relationship curve between drug diffusion accumulation and time to assist customers in analyzing release rates and optimizing formulations; At the same time, the quality balance research function supported by the equipment can accurately characterize the degree of dose consumption during IVRT, meeting the latest regulatory requirements for experimental data integrity standards, and providing strong support for customer product registration, filing, and quality control. '

The cooperation between Puni Group and Yiyan not only reflects Puni Group's continuous investment in upgrading detection technology, but also reflects the trend of domestic third-party detection institutions upgrading their demand for high-precision experimental equipment.

In the future, Puni Group will fully leverage the technological advantages of the YJZ-12000 drug transdermal diffusion analyzer from Yiyan, combined with its professional testing team and rich industry experience, to safeguard the innovative development of the pharmaceutical and cosmetics industries, help more enterprises break through technological bottlenecks, enhance product core competitiveness, and jointly promote the improvement of industry quality standards and healthy development.